Literature DB >> 3902432

Potential uses for metoclopramide.

A F Shaughnessy.   

Abstract

Metoclopramide, a dopamine antagonist, is approved in the U.S. for the treatment of various gastrointestinal disorders. Its use has been investigated in a wide variety of diseases, including those not involving the intestinal tract. Although more study is required before routine clinical use of metoclopramide can be advocated, it may be effective in the treatment of tardive dyskinesia, in decreasing the risk factors associated with anesthetic-related aspiration, and as an adjunct in the treatment of gastric bezoars. It also may be used safely in patients with Parkinson's disease. The use of metoclopramide in the treatment of neurogenic bladder, orthostatic hypotension, tumor-associated gastroparesis, nonprolactinemic amenorrhea, failure to thrive, Tourette's syndrome, anorexia nervosa, and hiccups, as well as an adjunct to migraine therapy, has been investigated, but sufficient evidence has not been accumulated to advocate the use of metoclopramide in these disorders.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3902432     DOI: 10.1177/106002808501901004

Source DB:  PubMed          Journal:  Drug Intell Clin Pharm        ISSN: 0012-6578


  3 in total

Review 1.  Pharmacological Agents Affecting Emesis : A Review (Part II).

Authors:  F Mitchelson
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

2.  Lactational failure--study of risk factors in Turkish mothers.

Authors:  M F Toppare; F Kitapci; D A Senses; I S Kaya; U Dilmen; Y Laleli
Journal:  Indian J Pediatr       Date:  1994 May-Jun       Impact factor: 1.967

3.  Premedication with metoclopramide decreases the frequency of methohexital induced hiccup.

Authors:  A Stav; N Weksler; M Berman; L Lemberg; L Ribak; A Segal; E Machamid; L Ovadia; A Sternberg
Journal:  J Anesth       Date:  1992-01       Impact factor: 2.078

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.